US2024041822A1PendingUtilityA1
Water soluble cannabis composition
Assignee: RIV CAPITAL US SERVICES LLCPriority: Jul 31, 2019Filed: Oct 12, 2023Published: Feb 8, 2024
Est. expiryJul 31, 2039(~13 yrs left)· nominal 20-yr term from priority
A61K 36/3482A61K 31/658A61K 31/352A61K 47/46A61K 9/14A61K 47/40A61K 9/08A61K 47/38A61K 9/146
65
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention provides a water-soluble composition comprising cannabis extract. The invention also provides methods of producing a water-soluble composition comprising cannabis extract. The invention further provides a solution comprising cannabis extract. Furthermore, the invention provides a frozen composition, a medication, a pharmaceutical composition, and a kit comprising a water-soluble composition comprising cannabis extract.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A composition comprising a cannabis extract wherein the extract further comprises a polysaccharide and wherein the composition is water-soluble.
2 . The composition of claim 1 , wherein the polysaccharide is selected from the group consisting of corn starch, coconut flour, potato starch, potato flour, arrowroot starch, Maltrin T-400, Microcrystalline Cellulose, Maltrin T-250, Uni-Pure WG220, Beta-Cyclodextrin, Isomalt 801, Isomalt 721, and a mixture thereof.
3 . The composition of claim 1 , wherein the cannabis extract comprises cannabis oil or cannabis tincture.
4 . The composition of claim 1 , wherein the cannabis extract comprises a mixture of cannabinoids.
5 . The composition of claim 4 , wherein the mixture of cannabinoids comprises tetrahydrocannabinol, tetrahydrocannabinolic acid, cannabidiol, cannabidiolic acid, cannabinol, cannabigerol, cannabichromene, cannabicyclol, cannabivarin, tetrahydrocannabivarin, cannabidivarin, cannabichromevarin, cannabigerovarin, cannabigerol monomethyl ether, cannabielsoin, or cannabicitran.
6 . The composition of claim 4 , wherein the mixture of cannabinoids comprises any two components selected from tetrahydrocannabinol, tetrahydrocannabinolic acid, cannabidiol, cannabidiolic acid, cannabinol, cannabigerol, cannabichromene, cannabicyclol, cannabivarin, tetrahydrocannabivarin, cannabidivarin, cannabichromevarin, cannabigerovarin, cannabigerol monomethyl ether, cannabielsoin, or cannabicitran.
7 . The composition of claim 6 , wherein the mixture of cannabinoids comprises any two components selected from the group consisting of tetrahydrocannabinol, tetrahydrocannabinolic acid, cannabidiol, cannabidiolic acid, cannabinol, cannabigerol, cannabichromene, cannabicyclol, cannabivarin, tetrahydrocannabivarin, cannabidivarin, cannabichromevarin, cannabigerovarin, cannabigerol monomethyl ether, cannabielsoin, and cannabicitran, wherein the two components are in a ratio of about 1:20.
8 . The composition of claim 6 , wherein the mixture of cannabinoids comprises any two components selected from the group consisting of tetrahydrocannabinol, tetrahydrocannabinolic acid, cannabidiol, cannabidiolic acid, cannabinol, cannabigerol, cannabichromene, cannabicyclol, cannabivarin, tetrahydrocannabivarin, cannabidivarin, cannabichromevarin, cannabigerovarin, cannabigerol monomethyl ether, cannabielsoin, and cannabicitran, wherein the two components are in a ratio of about 1:10.
9 . The composition of claim 6 , wherein the mixture of cannabinoids comprises any two components selected from the group consisting of tetrahydrocannabinol, tetrahydrocannabinolic acid, cannabidiol, cannabidiolic acid, cannabinol, cannabigerol, cannabichromene, cannabicyclol, cannabivarin, tetrahydrocannabivarin, cannabidivarin, cannabichromevarin, cannabigerovarin, cannabigerol monomethyl ether, cannabielsoin, and cannabicitran, wherein the two components are in a ratio of about 1:1.
10 . The composition of claim 1 , wherein the cannabis extract comprises a terpenoid.
11 . The composition of claim 1 , wherein the cannabis extract comprises a mixture of terpenoids.
12 . The composition of claim 10 , wherein the terpenoid is selected from alpha-bisabolol, borneol, alpha-caryophyllene, beta-caryophyllene, alpha elemene, beta elemene, gamma elemene, delta elemene, limonene, camphene, camphor, delta-3-carene, caryophyllene oxide, alpha-cedreen, citral, eucalyptol, beta-eudesmol, eudesm-7(11)-en-4-ol, farnesene, fenchol, alpha-guaiene, geraniol, guaiol, germacrene B, guaia-1(10)-11-diene, humulene, alpha-humulene, isobomeol, linalool, menthol, myrcene, alpha-myrcene, beta-myrcene, nerol, cis-ocimene, trans-ocimene, alpha-phellandrene, alpha-pinene, beta-pinene, pulegone, sabinene, alpha-terpinene, alpha-terpineol, terpinolene, terpineol, thymol, trans-2-pinanol, selina-3,7(1)-diene, or valencene.
13 . The composition of claim 11 , wherein the terpenoid is selected from alpha-bisabolol, borneol, alpha-caryophyllene, beta-caryophyllene, alpha elemene, beta elemene, gamma elemene, delta elemene, limonene, camphene, camphor, delta-3-carene, caryophyllene oxide, alpha-cedreen, citral, eucalyptol, beta-eudesmol, eudesm-7(11)-en-4-ol, farnesene, fenchol, alpha-guaiene, geraniol, guaiol, germacrene B, guaia-1(10)-11-diene, humulene, alpha-humulene, isobomeol, linalool, menthol, myrcene, alpha-myrcene, beta-myrcene, nerol, cis-ocimene, trans-ocimene, alpha-phellandrene, alpha-pinene, beta-pinene, pulegone, sabinene, alpha-terpinene, alpha-terpineol, terpinolene, terpineol, thymol, trans-2-pinanol, selina-3,7(1)-diene, or valencene.
14 . The composition of claim 10 , wherein the terpenoid comprises terpenoid oil or terpenoid tincture.
15 . The composition of claim 11 , wherein the terpenoid comprises terpenoid oil or terpenoid tincture.
16 . The composition of claim 1 , wherein the cannabis extract comprises a mixture of terpenoids and cannabinoids.
17 . The composition of claim 1 , wherein the polysaccharide is a powder.
18 . The powder composition of claim 17 , wherein the cannabis powder has a particle size of between about 200 to about 10 micrometer.
19 . The powder composition of claim 17 , wherein the cannabis powder has a particle size of about 180 to about 20 micrometers.
20 . A method of producing a water-soluble composition, wherein the water-soluble composition comprises a cannabis extract and wherein the extract further comprises a polysaccharide.
21 . The method of claim 20 , wherein the method comprises the steps of:
mixing a cannabis extract with a solvent to make a first mixture; combining the first mixture with a polysaccharide to make a second mixture; drying the second mixture; and sifting the dried second mixture through a mesh; thereby producing a water-soluble composition.
22 . The method of claim 21 , wherein the cannabis extract comprises cannabis oil or cannabis tincture.
23 . The method of claim 21 , wherein the cannabis extract comprises a mixture of cannabinoids.
24 . The method of claim 21 , wherein the cannabinoids are selected from the group consisting of tetrahydrocannabinol, tetrahydrocannabinolic acid, cannabidiol, cannabidiolic acid, cannabinol, cannabigerol, cannabichromene, cannabicyclol, cannabivarin, tetrahydrocannabivarin, cannabidivarin, cannabichromevarin, cannabigerovarin, cannabigerol monomethyl ether, cannabielsoin, and cannabicitran.
25 . The method of claim 21 , wherein the mixture of cannabinoids comprises any two components selected from the group consisting of tetrahydrocannabinol, tetrahydrocannabinolic acid, cannabidiol, cannabidiolic acid, cannabinol, cannabigerol, cannabichromene, cannabicyclol, cannabivarin, tetrahydrocannabivarin, cannabidivarin, cannabichromevarin, cannabigerovarin, cannabigerol monomethyl ether, cannabielsoin, and cannabicitran.
26 . The method of claim 21 , wherein the mixture of cannabinoids comprises any two components selected from the group consisting of tetrahydrocannabinol, tetrahydrocannabinolic acid, cannabidiol, cannabidiolic acid, cannabinol, cannabigerol, cannabichromene, cannabicyclol, cannabivarin, tetrahydrocannabivarin, cannabidivarin, cannabichromevarin, cannabigerovarin, cannabigerol monomethyl ether, cannabielsoin, and cannabicitran, wherein the components are in a ratio of about 1:20.
27 . The method of claim 21 , wherein the mixture of cannabinoids comprises any two components selected from the group consisting of tetrahydrocannabinol, tetrahydrocannabinolic acid, cannabidiol, cannabidiolic acid, cannabinol, cannabigerol, cannabichromene, cannabicyclol, cannabivarin, tetrahydrocannabivarin, cannabidivarin, cannabichromevarin, cannabigerovarin, cannabigerol monomethyl ether, cannabielsoin, and cannabicitran, wherein the components are in a ratio of about 1:10.
28 . The method of claim 21 , wherein the mixture of cannabinoids comprises any two components selected from the group consisting of tetrahydrocannabinol, tetrahydrocannabinolic acid, cannabidiol, cannabidiolic acid, cannabinol, cannabigerol, cannabichromene, cannabicyclol, cannabivarin, tetrahydrocannabivarin, cannabidivarin, cannabichromevarin, cannabigerovarin, cannabigerol monomethyl ether, cannabielsoin, and cannabicitran, wherein the components are in a ratio of about 1:1.
29 . The method of claim 21 , wherein the cannabis extract comprises a terpenoid.
30 . The method of claim 21 , wherein the cannabis extract comprises a mixture of terpenoids.
31 . The method of claim 29 , wherein the terpenoid is selected from the group consisting of alpha-bisabolol, borneol, alpha-caryophyllene, beta-caryophyllene, alpha elemene, beta elemene, gamma elemene, delta elemene, limonene, camphene, camphor, delta-3-carene, caryophyllene oxide, alpha-cedreen, citral, eucalyptol, beta-eudesmol, eudesm-7(11)-en-4-ol, farnesene, fenchol, alpha-guaiene, geraniol, guaiol, germacrene B, guaia-1(10)-11-diene, humulene, alpha-humulene, isobomeol, linalool, menthol, myrcene, alpha-myrcene, beta-myrcene, nerol, cis-ocimene, trans-ocimene, alpha-phellandrene, alpha-pinene, beta-pinene, pulegone, sabinene, alpha-terpinene, alpha-terpineol, terpinolene, terpineol, thymol, trans-2-pinanol, selina-3,7(1)-diene, and valencene.
32 . The method of claim 30 , wherein the terpenoid is selected from the group consisting of alpha-bisabolol, borneol, alpha-caryophyllene, beta-caryophyllene, alpha elemene, beta elemene, gamma elemene, delta elemene, limonene, camphene, camphor, delta-3-carene, caryophyllene oxide, alpha-cedreen, citral, eucalyptol, beta-eudesmol, eudesm-7(11)-en-4-ol, farnesene, fenchol, alpha-guaiene, geraniol, guaiol, germacrene B, guaia-1(10)-11-diene, humulene, alpha-humulene, isobomeol, linalool, menthol, myrcene, alpha-myrcene, beta-myrcene, nerol, cis-ocimene, trans-ocimene, alpha-phellandrene, alpha-pinene, beta-pinene, pulegone, sabinene, alpha-terpinene, alpha-terpineol, terpinolene, terpineol, thymol, trans-2-pinanol, selina-3,7(1)-diene, and valencene.
33 . The method of claim 29 , wherein the terpenoid comprises terpenoid oil or terpenoid tincture.
34 . The method of claim 30 , wherein the terpenoid comprises terpenoid oil or terpenoid tincture.
35 . The method of claim 21 , wherein the cannabis extract comprises a mixture of terpenoids and cannabinoids.
36 . The method of claim 21 , wherein the solvent is selected from methanol, ethanol, propanol, butanol, or other alcohols, or a mixture thereof.
37 . The method of claim 21 , wherein the solvent is ethanol.
38 . The method of claim 21 , wherein the polysaccharide is a plant-based sugar.
39 . The method of claim 21 , wherein the polysaccharide is a powder.
40 . The method of claim 21 , wherein the polysaccharide is selected from the group consisting of corn starch, coconut flour, potato starch, potato flour, arrowroot starch, Maltrin T-400, Microcrystalline Cellulose, Maltrin T-250, Uni-Pure WG220, Beta-Cyclodextrin, Isomalt 801, Isomalt 721, and a mixture thereof.
41 . The method of claim 39 , wherein the powder has a particle size of between about 450 to about 1 micrometer.
42 . The method of claim 39 , wherein the powder has a particle size of about 180 to about 10 micrometers.
43 . A solution comprising the composition of claim 1 .
44 . A frozen composition comprising the composition of claim 1 .
45 . A medication comprising the composition of claim 1 .
46 . A pharmaceutical composition comprising the composition of claim 1 .
47 . A kit comprising the composition of claim 1 .
48 . A kit comprising the composition of claim 43 .
49 . A kit comprising the composition of claim 44 .Join the waitlist — get patent alerts
Track US2024041822A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.